Team | Year | Age | GS | G | IP | W | L | SV | BS | K | BB | H | HR | K% | BB% | HR% | LOB% | GB% | WHIP | BABIP | ERA | FIP | FIP- | xFIP | E-F | WAR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ocala - CPL (A)
OCA - CPL (A)
|
2043 | 24 | 0 | 110 | 114.2 | 1 | 18 | 9 | 7 | 104 | 189 | 161 | 18 | 15.3% | 27.75% | 2.6% | 52.1% | 52.8% | 3.05 | .404 | 13.97 | 8.43 | 177 | 7.61 | 5.54 | -4.27 |
Ocala - CPL (A)
OCA - CPL (A)
|
2042 | 23 | 33 | 34 | 149.2 | 6 | 11 | 0 | 0 | 101 | 95 | 142 | 9 | 14.7% | 13.83% | 1.3% | 66.6% | 58.7% | 1.58 | .286 | 5.17 | 5.03 | 107 | 5.49 | 0.14 | 1.50 |
Ocala - CPL (A)
OCA - CPL (A)
|
2041 | 22 | 30 | 30 | 165.0 | 10 | 8 | 0 | 0 | 122 | 29 | 145 | 18 | 18.2% | 4.33% | 2.7% | 70.4% | 54.2% | 1.05 | .259 | 3.22 | 3.67 | 89 | 4.22 | -0.46 | 3.22 |
Ocala - CPL (A)
OCA - CPL (A)
|
2040 | 21 | 31 | 31 | 146.1 | 8 | 7 | 0 | 0 | 112 | 47 | 146 | 27 | 17.8% | 7.48% | 4.3% | 72.4% | 60.9% | 1.32 | .279 | 4.61 | 5.02 | 129 | 4.21 | -0.40 | -0.12 |
Ocala - CPL (A)
OCA - CPL (A)
|
2039 | 20 | 0 | 4 | 7.0 | 1 | 0 | 1 | 0 | 8 | 0 | 1 | 0 | 36.4% | 0.00% | 0.0% | 100.0% | 69.2% | 0.14 | .071 | 0.00 | 0.61 | 16 | 1.72 | -0.61 | 0.34 |
Caracas - DRAKE
CAR - DRAKE
|
2039 | 20 | 1 | 13 | 29.2 | 1 | 0 | 2 | 0 | 36 | 13 | 21 | 1 | 29.0% | 10.48% | 0.8% | 78.0% | 56.9% | 1.15 | .278 | 2.73 | 2.24 | 53 | 3.03 | 0.49 | 0.93 |
Caracas - DRAKE
CAR - DRAKE
|
2038 | 19 | 0 | 12 | 16.2 | 2 | 1 | 2 | 0 | 11 | 10 | 12 | 0 | 16.7% | 15.15% | 0.0% | 54.5% | 63.6% | 1.32 | .267 | 5.40 | 2.47 | 64 | 3.59 | 2.93 | 0.47 |
Anheiser-Busch - CCAS (COL)
AHB - CCAS (COL)
|
2038 | 19 | 10 | 10 | 54.2 | 3 | 2 | 0 | 0 | 56 | 19 | 45 | 6 | 24.7% | 8.37% | 2.6% | 85.1% | 54.5% | 1.17 | .275 | 2.80 | 3.55 | 77 | 4.06 | -0.75 | 1.47 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2037 | 18 | 0 | 17 | 17.2 | 1 | 0 | 9 | 1 | 21 | 7 | 14 | 2 | 28.8% | 9.59% | 2.7% | 78.1% | 48.3% | 1.19 | .286 | 3.06 | 4.03 | 72 | 4.82 | -0.98 | 0.42 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2036 | 17 | 0 | 15 | 14.1 | 2 | 2 | 7 | 0 | 19 | 11 | 10 | 0 | 27.5% | 15.94% | 0.0% | 88.5% | 42.9% | 1.47 | .294 | 1.88 | 3.69 | 74 | 5.59 | -1.81 | 0.46 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2035 | 16 | 0 | 16 | 22.0 | 2 | 1 | 9 | 0 | 27 | 14 | 16 | 0 | 29.7% | 15.38% | 0.0% | 86.7% | 61.8% | 1.36 | .320 | 1.64 | 2.65 | 48 | 3.97 | -1.02 | 0.99 |
Pfizer - IFC
PFZ - IFC
|
2034 | 15 | 0 | 21 | 23.1 | 2 | 3 | 9 | 2 | 20 | 22 | 22 | 1 | 16.7% | 18.33% | 0.8% | 78.5% | 59.2% | 1.89 | .288 | 3.47 | 5.44 | 93 | 6.82 | -1.97 | 0.29 |
Total - A
A
|
94 | 209 | 582.2 | 26 | 44 | 10 | 7 | 447 | 360 | 595 | 72 | 16.6% | 13.39% | 2.7% | 63.0% | 57.0% | 1.64 | .299 | 6.15 | 5.26 | 120 | 5.18 | 0.89 | 0.67 | ||
Total - S A
S A
|
1 | 25 | 46.1 | 3 | 1 | 4 | 0 | 47 | 23 | 33 | 1 | 24.7% | 12.11% | 0.5% | 68.9% | 59.5% | 1.21 | .274 | 3.69 | 2.32 | 57 | 3.24 | 1.37 | 1.40 | ||
Total - HS
HS
|
10 | 31 | 78.0 | 5 | 5 | 9 | 2 | 76 | 41 | 67 | 7 | 21.9% | 11.82% | 2.0% | 82.2% | 56.1% | 1.38 | .279 | 3.00 | 4.12 | 82 | 4.89 | -1.12 | 1.75 | ||
Total - HS
HS
|
0 | 48 | 54.0 | 5 | 3 | 25 | 1 | 67 | 32 | 40 | 2 | 28.8% | 13.73% | 0.9% | 85.1% | 52.4% | 1.33 | .302 | 2.17 | 3.38 | 63 | 4.68 | -1.21 | 1.87 | ||
Total - Minors
Minors
|
95 | 234 | 629.0 | 29 | 45 | 14 | 7 | 494 | 383 | 628 | 73 | 17.2% | 13.31% | 2.5% | 63.3% | 57.2% | 1.61 | .297 | 5.97 | 5.04 | 115 | 5.04 | 0.92 | 2.07 |